Entero Therapeutics, Inc. Quarterly Current Ratio in % from Q2 2017 to Q4 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Entero Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2017 to Q4 2024.
  • Entero Therapeutics, Inc. Current Ratio for the quarter ending December 31, 2024 was 400 %, a 211% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2024 400 +271 +211% Dec 31, 2024
Q3 2024 447 +325 +266% Sep 30, 2024
Q2 2024 371 +292 +372% Jun 30, 2024
Q1 2024 125 +86 +222% Mar 31, 2024
Q4 2023 129 +93.7 +266% Dec 31, 2023
Q3 2023 122 +82.1 +204% Sep 30, 2023
Q2 2023 78.6 +38.5 +95.8% Jun 30, 2023
Q1 2023 38.8 -22.9 -37.1% Mar 31, 2023
Q4 2022 35.2 -58.3 -62.4% Dec 31, 2022
Q3 2022 40.2 -43 -51.6% Sep 30, 2022
Q2 2022 40.2 -106 -72.5% Jun 30, 2022
Q1 2022 61.6 -54.8 -47% Mar 31, 2022
Q4 2021 93.5 +16.2 +20.9% Dec 31, 2021
Q3 2021 83.2 -15.7 -15.9% Sep 30, 2021
Q2 2021 146 +95.2 +187% Jun 30, 2021
Q1 2021 116 +52.8 +82.9% Mar 31, 2021
Q4 2020 77.3 +15.8 +25.8% Dec 31, 2020
Q3 2020 98.9 +26.9 +37.4% Sep 30, 2020
Q2 2020 50.9 -52 -50.5% Jun 30, 2020
Q1 2020 63.6 -107 -62.8% Mar 31, 2020
Q4 2019 61.5 -150 -70.9% Dec 31, 2019
Q3 2019 72 -121 -62.7% Sep 30, 2019
Q2 2019 103 -43.5 -29.7% Jun 30, 2019
Q1 2019 171 +57.8 +51.1% Mar 31, 2019
Q4 2018 212 +97.2 +85% Dec 31, 2018
Q3 2018 193 +67.1 +53.4% Sep 30, 2018
Q2 2018 146 +98.3 +205% Jun 30, 2018
Q1 2018 113 Mar 31, 2018
Q4 2017 114 Dec 31, 2017
Q3 2017 126 Sep 30, 2017
Q2 2017 48.1 Jun 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.